Le Lézard
Classified in: Health, Business
Subject: LIC

Getlabs and Instalab Announce Nationwide Partnership to Bring Prevention-Based Medicine to Everyone


MIAMI, April 23, 2024 /PRNewswire/ -- Getlabs, the nationwide leader for at-home diagnostics, is excited to announce a strategic partnership with Instalab, a pioneering proactive healthcare company. Through Getlabs' widespread presence throughout the United States, Instalab can provide advanced at-home blood testing and personalized health guidance on a national scale.

This strategic alliance represents a pivotal advancement in healthcare delivery, merging Getlabs' diagnostics collections expertise with Instalab's innovative testing and assessments to dramatically improve patient access to truly proactive healthcare.

"Through this partnership, we're not just providing tests; we're delivering peace of mind to patients, right in the comfort of their homes," said Kyle Michelson, CEO of Getlabs. "Partnering with Instalab allows us to expand our reach and amplify our impact, ultimately ensuring that patients receive the care they need, when they need it."

Adora Cheung, CEO of Instalab, commented on the partnership's impact, saying, "We've set a new standard for what healthcare should be: prevention-based, individualized and comprehensive. This partnership allows us to help millions more patients in managing their health proactively in particular with our Longevity Panel."

About Getlabs
Getlabs is the nationwide leader for at-home diagnostics. Healthcare organizations use our all-in-one platform to dispatch skilled medical specialists to their patients and collect labs, vitals, and advanced diagnostics. By partnering with Getlabs, providers can expand access to care, improve adherence, and make informed medical decisions remotely. Learn more.

About Instalab
Instalab is a health concierge service that guides each member with a personalized action plan on how to live a longer, better life. This includes direct, convenient access to advanced testing, specialist physicians, tailored medications and more. Learn more.

The Instalab Longevity Panel enables patients to test for over 60 biomarkers at once and includes detailed analyses that early detects potential health risks and delivers expert guidance for effective management and resolution.

SOURCE Getlabs


These press releases may also interest you

at 19:19
Statement: The Government of Canada provides an update on the Highly Pathogenic Avian Influenza
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Welcomes Experienced Urology Executive to its Helm
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. Closes First Tranche of Private Placement
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 18:29
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...

at 18:20
National Institutes of Health All of Us Research Program Mobile Tour Visits Rochester, NY
Starting this week, National Alliance for Hispanic Health, Ibero American Action League Inc., University of Rochester Medical Center, and Trillium Health in Rochester, NY will host the All of Us Journey, a traveling educational exhibit that brings...

at 18:00
BetterLife Announces Intent to Complete Private Placement of Units
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

More news about Health...


News published on and distributed by: